Longeveron Laromestrocel Therapy Shows Promise for Alzheimer’s Inflammation July 13, 2026 Read More »
Kenai Therapeutics Completes Phase 1b/2a Trial Enrollment for Parkinson’s Cell Therapy July 7, 2026 Read More »
World’s First Neural Stem Cell Trial for Huntington’s Disease: A New Horizon of Hope June 30, 2026 Read More »
